Skip to content
Search

Latest Stories

NHS introduces flash glucose monitors for all type 1 diabetes patients

Type 1 diabetes patients can monitor their glucose with the newly introduced flash glucose monitors by the NHS.

The wearable gadgets with the size of a £2 coin, have a sensor that easily sits on the arm, allowing patients to check their glucose levels with a one-second scan.


Eligible patients are currently able to access the monitors on prescription from their local GP or diabetes team, helping them to better manage their blood sugar levels.

Everyone living with type 1 diabetes will be eligible for lifechanging flash glucose monitors on the NHS. The NHS Long Term Plan has already helped almost three in five people with Type 1 diabetes to access the monitors that allow people to check their glucose levels more easily and regularly.

The change, confirmed today by the National Institute for Health and Care Excellence (NICE), means that everyone in England with the condition will be able to benefit from the convenient technology.

Monitors link to an easy to use app on your phone, where people can access the data gathered by the device. Unlike conventional monitors they allow patients to view patterns over time, not only showing current and previous glucose levels but also predicting what level they can rise to.

New research presented this week at the Diabetes UK Professional Conference 2022 revealed that flash monitoring not only helps to improve blood glucose levels in people with type 1 diabetes, but also has a positive effect on their quality of life.

The NHS Long Term Plan included a target to ensure 20 per cent of people with type 1 diabetes were benefiting from flash monitors by March 2021 and recent data shows the NHS significantly exceeded that goal, with nearly three fifths already accessing the technology.

The NHS is taking radical action to tackle and treat diabetes, including through the world leading NHS Diabetes Prevention Programme with new research showing thousands of people are being spared type 2 diabetes thanks to the scheme.

The NHS in England currently spends around £10 billion a year on diabetes – around 10 per cent of its entire budget. Tools like continuous glucose monitoring, which help patients better manage their condition and reduce associated illness and hospitalisations, can prove hugely cost effective.

National NHS Specialty Adviser for Diabetes, Professor Partha Kar, said: “This announcement is the biggest step forward for type 1 diabetes care in years, allowing everyone eligible to have one of these easy to use pieces of tech if they want to – building on the success of the NHS in its rollout so far. I am delighted to see NICE endorse the use of this technology.

“These monitors are a win win – they support diabetes patients to live healthier lives, reduce their risk of hospitalisation while also helping to reduce pressure on NHS services and provide better value for money for taxpayers”.

Olivia aged 25 from Essex, who was diagnosed with type 1 diabetes aged seven said: “Before I started using a flash glucose monitor, I carried my blood glucose testing kit with me everywhere and would have to test up to eight times per day – I was pricking my finger and testing my blood sugar before breakfast, before lunch, before dinner and before bed. Before driving in the car I would need to test, and after driving for two hours I would need to stop to test – endless testing!

“Growing up with diabetes, I’d never dreamed that a device like a flash glucose monitor, where you don’t need to finger prick to know what your levels are, would be developed in my lifetime – and when I first started using one, I couldn’t quite believe something so small had such an impact on managing my diabetes.

“Since using a flash monitor, I’ve seen a huge improvement as I can make informed decisions when taking my insulin by looking at trends. But, most importantly, it’s helped me have more confidence and improved my mental well-being”.

More For You

Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less